A number of new therapies for the treatment of Cystic Fibrosis are in the process of clinical trials and are expected to be submitted to the FDA for approval in the near future. These could be an exciting breakthrough for all who live with CF.
We seek to speak with patients (or parents of) who have participated in some of these clinical trials. The objective is to learn about how the addition of these new therapies impacts patients' overall CF treatment process.
We are specifically interested in patients (or parents of) who have taken part in clinical trials (or open label extensions) either past or present, for Bronchitol, Denufosol and Vertex 770.
Interviews will be one hour by phone/web and may be scheduled between June 17th and June 23rd and participants receive an honorarium of $175.
We are also able to offer a donation to any referring organization,advocate or person of $100 each, for helping us get this opportunity out to your community.
Please respond to below contacts to schedule or if you have any questions.
Kind Regards,
Jan
Jan Mallery-Groom RN
Clinical Research Support Services
+510-922-9710
jmallery@comcast.net
We seek to speak with patients (or parents of) who have participated in some of these clinical trials. The objective is to learn about how the addition of these new therapies impacts patients' overall CF treatment process.
We are specifically interested in patients (or parents of) who have taken part in clinical trials (or open label extensions) either past or present, for Bronchitol, Denufosol and Vertex 770.
Interviews will be one hour by phone/web and may be scheduled between June 17th and June 23rd and participants receive an honorarium of $175.
We are also able to offer a donation to any referring organization,advocate or person of $100 each, for helping us get this opportunity out to your community.
Please respond to below contacts to schedule or if you have any questions.
Kind Regards,
Jan
Jan Mallery-Groom RN
Clinical Research Support Services
+510-922-9710
jmallery@comcast.net